Page last updated: 2024-09-05
dabigatran and e 5555
dabigatran has been researched along with e 5555 in 1 studies
Compound Research Comparison
| Studies (dabigatran) | Trials (dabigatran) | Recent Studies (post-2010) (dabigatran) | Studies (e 5555) | Trials (e 5555) | Recent Studies (post-2010) (e 5555) |
|---|---|---|---|---|---|
| 3,887 | 261 | 3,490 | 47 | 4 | 34 |
Protein Interaction Comparison
| Protein | Taxonomy | dabigatran (IC50) | e 5555 (IC50) |
|---|---|---|---|
| Proteinase-activated receptor 1 | Homo sapiens (human) | 0.0323 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Goto, S; Tomita, A | 1 |
Reviews
1 review(s) available for dabigatran and e 5555
| Article | Year |
|---|---|
New antithrombotics for secondary prevention of acute coronary syndrome.
Topics: Acute Coronary Syndrome; Anticoagulants; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Coronary Thrombosis; Dabigatran; Hemorrhage; Humans; Imines; Lactones; Morpholines; Platelet Activation; Platelet Aggregation Inhibitors; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Secondary Prevention; Thiophenes; Thrombin | 2014 |